He obtained his DVM at LMU Munich (Germany) and did his postdoc training at Duke University (USA). His group focuses on the fundamental aspects of bacterial toxins from Bacillus cereus and other bacterial pathogens. He is also interested in developing short, linear antibacterial peptides inspired antibiotics to target multidrug resistant bacteria.
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.
